Beneficial effects of C-peptide on renal morphology in diabetic rats

Acta Biochimica et Biophysica Sinica

Volumn 42, Issue 12, 2010, Pages 893-899

  Sun, Wei ^a   Gao, Xin ^a   Zhao, Xiaolong ^b   Cui, Dafu ^c   Xia, Qichang ^c  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

^c INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

Author keywords

C peptide; diabetic rat; mesangial cell; mesangial matrix; type IV collagen

Indexed keywords

C PEPTIDE; COLLAGEN TYPE 4; GELATINASE A; STREPTOZOCIN;

ANIMAL; ARTICLE; CHEMICALLY INDUCED DISORDER; DIABETIC NEPHROPATHY; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL DIABETES MELLITUS; GENE EXPRESSION REGULATION; GENETICS; MESANGIUM; METABOLISM; PATHOLOGY; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPRAGUE DAWLEY RAT; TIME;

ANIMALS; C-PEPTIDE; COLLAGEN TYPE IV; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; GLOMERULAR MESANGIUM; MATRIX METALLOPROTEINASE 2; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STREPTOZOCIN; TIME FACTORS;

RATTUS;

EID: 78649678179     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1093/abbs/gmq100     Document Type: Article

References (17)

1. Johansson BL, Sjöberg S and Wahren J. The influence of human C-peptide on renal function and glucose utilization in type 1 (insulin-dependent) diabetic patients. Diabetologia 1992, 35: 121-128.
2. Johansson BL, Kernell A, Sjöberg S and Wahren J. Influence of combined C-peptide and insulin administration on renal function and metabolic control in diabetes type 1. J Clin Endocrinol Metab 1993, 77: 976-981.
3. Johansson BL, Borg K, Fernqvist-Forbes E, Kernell A, Odergren T and Wahren J. Beneficial effects of C-peptide on incipient nephropathy and neuropathy in patients with type 1 diabetes mellitus. Diabet Med 2000, 17: 181-189.
4. Sjöquist M, Huang W and Johansson BL. Effects of C-peptide on renal function at the early stage of experimental diabetes. Kidney Int 1998, 54: 758-764.
5. Samnegard B, Jacobson SH, Jaremko G, Johansson BL and Sjöquist M. Effects of C-peptide on glomerular and renal size and renal function in diabetic rats. Kidney Int 2001, 60: 1258-1265.
6. Samnegard B, Jacobson SH, Jaremko G, Johansson BL, Ekberg K, Isaksson B and Eriksson L, et al. C-peptide prevents glomerular hypertrophy and mesangial matrix expansion in diabetic rats. Nephrol Dial Transplant 2005, 20: 532-538.
7. Adler S. Structure-function relationships associated with extracellular matrix alterations in diabetic glomerulopathy. J Am Soc Nephrol 1994, 5: 1165-1172.
8. Lenz O, Elliot SJ and Stetler-Stevenson WG. Matrix metalloproteinases in renal development and disease. J Am Soc Nephrol 2000, 11: 574-581.
9. Salamonsen LA. Matrix metalloproteinases and their tissue inhibitors in endocrinology. Trends Endocrinol Metab 1996, 7: 28-34.
10. Nagase H and Woessner JF. Matrix metalloproteinases. J Biol Chem 1999, 274: 21491-21494.
11. Li MY, Liu ZH, Shao XX, Xia QC, Zhou GM, Lin QS and Cui DF. Synthesis of human proinsulin C-peptide and preparation of specific antibody to it. Acta Biochim Biophy Sinica 2000, 32: 665-668.
12. Rebsomen L, Pitel S, Boubred F, Buffat C, Feuerstein JM, Raccah D and Vague P, et al. C-peptide replacement improves weight gain and renal function in diabetic rats. Diabetes Metab 2006, 32: 223-228.
13. Ido Y, Vindigni A, Chang K, Stramm L, Chance R, Heath WF and DiMarchi RD, et al. Prevention of vascular and neural dysfunction in diabetic rats by C-peptide. Science 1997, 227: 563-566.
14. Maezawa Y, Yokote K, Sonezaki K, Fujimoto M, Kobayashi K, Kawamura H and Tokuyama T, et al. Influence of C-peptide on early glo-merular changes in diabetic mice. Diabetes Metab Res Rev 2006, 22: 313-322.
15. Mauer SM. Structural-functional correlations of diabetic nephropathy. Kidney Int 1994, 45: 612-622.
16. Rasch R and Dørup J. Quantitative morphology of the rat kidney during diabetes mellitus and insulin treatment. Diabetologia 1997, 40: 802-809.
17. McLennan SV, Fisher E, Martell SY, Death AK, Williams PF, Lyons JG and Yue DK. Effects of glucose on matrix metalloproteinase and plasmin activities in mesangial cells: possible role in diabetic nephropathy. Kidney Int 2000, 58(Suppl.77): S81-S87.